Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Varun Mehra

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Bone Marrow Transplantation|November 29, 2025
Microbiotherapy and fecal microbiota transplantation in hematology-oncology: a European clinical perspective to navigate the evolving regulatory framework and the emergence of a new therapeutic classFlorent Malard, Ernst Holler, Zinaida Peric, et al.
Mediterranean Journal of Hematology and Infectious Diseases|January 15, 2024
Haploidentical Transplant with Post-Transplant Cyclophosphamide for Acute Myeloid Leukaemia and Myelodysplastic Syndromes Patients: The Role of Previous Lines of TherapyDaniele Avenoso, Fabio Serpenti, Liron Barnea Slonim, et al.
Leukemia|June 2, 2025
Post-pandemic recommendations for the management of COVID-19 in patients with haematological malignancies or undergoing cellular therapy, from the European Conference on Infections in Leukaemia (ECIL-10)Simone Cesaro, Per Ljungman, Malgorzata Mikulska, et al.
Mediterranean Journal of Hematology and Infectious Diseases|July 12, 2023
Fludarabine-Melphalan-Campath, Followed by Unmanipulated Peripheral-Blood Haematopoietic Stem Cells, Can Still Cure LymphomaDaniele Avenoso, Amal Alabdulwahab, Michelle Kenyon, et al.
Leukemia|August 4, 2025
Author's Reply to the correspondence: ECIL-10 guidelines for COVID-19 should take convalescent plasma into proper consideration by Focosi et alSimone Cesaro, Per Ljungman, Malgorzata Mikulska, et al.
Neurology|July 13, 2021
Autologous Hematopoietic Stem Cell Transplantation in Active Multiple Sclerosis: A Real-world Case SeriesRichard S Nicholas, Elijah E Rhone, Alice Mariottini, et al.
Blood Advances|October 25, 2019
Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50 yearsVipul Sharad Sheth, Victoria Potter, Shreyans A Gandhi, et al.
Annals of Neurology|April 19, 2025
Effectiveness of Autologous Hematopoietic Stem Cell Transplantation versus Alemtuzumab and Ocrelizumab in Relapsing Multiple Sclerosis: A Single Center Cohort StudyPaolo Antonio Muraro, Antonio Zito, Alessio Signori, et al.
Open Forum Infectious Diseases|July 24, 2024
The Impact of the Fungal Priority Pathogens List on Medical Mycology: A Northern European PerspectiveMaiken Cavling Arendrup, Darius Armstrong-James, Andrew M Borman, et al.
Cancer Cell|December 15, 2021
Repeated vaccination against SARS-CoV-2 elicits robust polyfunctional T cell response in allogeneic stem cell transplantation recipientsPatrick Harrington, Katie J Doores, Chandan Saha, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Bone Marrow Transplantation|November 29, 2025
Microbiotherapy and fecal microbiota transplantation in hematology-oncology: a European clinical perspective to navigate the evolving regulatory framework and the emergence of a new therapeutic classFlorent Malard, Ernst Holler, Zinaida Peric, et al.
Mediterranean Journal of Hematology and Infectious Diseases|January 15, 2024
Haploidentical Transplant with Post-Transplant Cyclophosphamide for Acute Myeloid Leukaemia and Myelodysplastic Syndromes Patients: The Role of Previous Lines of TherapyDaniele Avenoso, Fabio Serpenti, Liron Barnea Slonim, et al.
Leukemia|June 2, 2025
Post-pandemic recommendations for the management of COVID-19 in patients with haematological malignancies or undergoing cellular therapy, from the European Conference on Infections in Leukaemia (ECIL-10)Simone Cesaro, Per Ljungman, Malgorzata Mikulska, et al.
Mediterranean Journal of Hematology and Infectious Diseases|July 12, 2023
Fludarabine-Melphalan-Campath, Followed by Unmanipulated Peripheral-Blood Haematopoietic Stem Cells, Can Still Cure LymphomaDaniele Avenoso, Amal Alabdulwahab, Michelle Kenyon, et al.
Leukemia|August 4, 2025
Author's Reply to the correspondence: ECIL-10 guidelines for COVID-19 should take convalescent plasma into proper consideration by Focosi et alSimone Cesaro, Per Ljungman, Malgorzata Mikulska, et al.
Neurology|July 13, 2021
Autologous Hematopoietic Stem Cell Transplantation in Active Multiple Sclerosis: A Real-world Case SeriesRichard S Nicholas, Elijah E Rhone, Alice Mariottini, et al.
Blood Advances|October 25, 2019
Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50 yearsVipul Sharad Sheth, Victoria Potter, Shreyans A Gandhi, et al.
Annals of Neurology|April 19, 2025
Effectiveness of Autologous Hematopoietic Stem Cell Transplantation versus Alemtuzumab and Ocrelizumab in Relapsing Multiple Sclerosis: A Single Center Cohort StudyPaolo Antonio Muraro, Antonio Zito, Alessio Signori, et al.
Open Forum Infectious Diseases|July 24, 2024
The Impact of the Fungal Priority Pathogens List on Medical Mycology: A Northern European PerspectiveMaiken Cavling Arendrup, Darius Armstrong-James, Andrew M Borman, et al.
Cancer Cell|December 15, 2021
Repeated vaccination against SARS-CoV-2 elicits robust polyfunctional T cell response in allogeneic stem cell transplantation recipientsPatrick Harrington, Katie J Doores, Chandan Saha, et al.
Pageof 5